Skip to main content
Premium Trial:

Request an Annual Quote

David Arnold, Gunter Thebeling, Fran Tuttle

Third Wave Technologies has appointed David Arnold to its board of directors. Arnold is a former VP and CTO of Kennametal, where he worked for 24 years.
 

 
Fluorotechnics has appointed Günter Thebeling to head its sales and marketing team. Thebeling formerly was strategic marketing director for proteomics products at GE Healthcare and was responsible for managing relationships with pharmaceutical partners and with scientific organizations such as the Human Proteome Organization.
 

 
Fran Tuttle has been appointed to join Xceed Molecular’s board of trustees. Tuttle is president and CEO of HX Diagnostics, and formerly was CEO of Protedyne, and senior VP of near patient testing at Bayer Diagnostics. Before that she worked at Chiron Diagnostics.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.